Hybrid cellular membrane nanovesicles amplify macrophage immune responses against cancer recurrence and metastasis

[1]  A. Jemal,et al.  Cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.

[2]  Rui Tian,et al.  Cancer Cell Membrane‐Coated Nanoparticles for Personalized Therapy in Patient‐Derived Xenograft Models , 2019, Advanced Functional Materials.

[3]  R. Medzhitov,et al.  Harnessing innate immunity in cancer therapy , 2019, Nature.

[4]  Robert Langer,et al.  Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation , 2019, Nature Biotechnology.

[5]  Betty Y. S. Kim,et al.  Phagocytosis checkpoints as new targets for cancer immunotherapy , 2019, Nature Reviews Cancer.

[6]  Mingyi Chen,et al.  Hypofractionated EGFR tyrosine kinase inhibitor limits tumor relapse through triggering innate and adaptive immunity , 2019, Science Immunology.

[7]  Weidong Chen,et al.  Exosomes from M1-Polarized Macrophages Enhance Paclitaxel Antitumor Activity by Activating Macrophages-Mediated Inflammation , 2019, Theranostics.

[8]  Quanyin Hu,et al.  In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment , 2018, Nature Nanotechnology.

[9]  Mark Kelley,et al.  Endosomolytic Polymersomes Increase the Activity of Cyclic Dinucleotide STING Agonists to Enhance Cancer Immunotherapy , 2018, Nature Nanotechnology.

[10]  J. Moon,et al.  Dendritic Cell Membrane Vesicles for Activation and Maintenance of Antigen‐Specific T Cells , 2018, Advanced healthcare materials.

[11]  I. Weissman,et al.  CD47 Blockade by Hu5F9‐G4 and Rituximab in Non‐Hodgkin's Lymphoma , 2018, The New England journal of medicine.

[12]  David W. Greening,et al.  Extracellular vesicles in cancer — implications for future improvements in cancer care , 2018, Nature Reviews Clinical Oncology.

[13]  Timothy A. Chan,et al.  The hallmarks of successful anticancer immunotherapy , 2018, Science Translational Medicine.

[14]  Yeon Woong Choo,et al.  M1 Macrophage-Derived Nanovesicles Potentiate the Anticancer Efficacy of Immune Checkpoint Inhibitors. , 2018, ACS nano.

[15]  Xingzhong Zhao,et al.  Platelet–Leukocyte Hybrid Membrane‐Coated Immunomagnetic Beads for Highly Efficient and Highly Specific Isolation of Circulating Tumor Cells , 2018, Advanced Functional Materials.

[16]  Xiufeng Yan,et al.  Platelet-camouflaged nanococktail: Simultaneous inhibition of drug-resistant tumor growth and metastasis via a cancer cells and tumor vasculature dual-targeting strategy , 2018, Theranostics.

[17]  Xiaoyuan Chen,et al.  Genetically Engineered Liposome‐like Nanovesicles as Active Targeted Transport Platform , 2018, Advanced materials.

[18]  W. Liu,et al.  Platelet-Facilitated Photothermal Therapy of Head and Neck Squamous Cell Carcinoma. , 2018, Angewandte Chemie.

[19]  Graça Raposo,et al.  Shedding light on the cell biology of extracellular vesicles , 2018, Nature Reviews Molecular Cell Biology.

[20]  Chwee Teck Lim,et al.  Exosomes in Cancer Nanomedicine and Immunotherapy: Prospects and Challenges. , 2017, Trends in biotechnology.

[21]  Raghu Kalluri,et al.  Exosomes Facilitate Therapeutic Targeting of Oncogenic Kras in Pancreatic Cancer , 2017, Nature.

[22]  Zhijian J. Chen,et al.  A STING-Activating Nanovaccine for Cancer Immunotherapy , 2017, Nature nanotechnology.

[23]  Theresa A. Storm,et al.  Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors , 2017, Science Translational Medicine.

[24]  Yoosoo Yang,et al.  Exosome-SIRPα, a CD47 blockade increases cancer cell phagocytosis. , 2017, Biomaterials.

[25]  Alberto Mantovani,et al.  Tumour-associated macrophages as treatment targets in oncology , 2017, Nature Reviews Clinical Oncology.

[26]  Zhen Gu,et al.  In situ activation of platelets with checkpoint inhibitors for post-surgical cancer immunotherapy , 2017, Nature Biomedical Engineering.

[27]  A. De Vita,et al.  Biomimetic proteolipid vesicles for targeting inflamed tissues , 2016, Nature materials.

[28]  F. Martinon,et al.  STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity , 2015, Proceedings of the National Academy of Sciences.

[29]  Rui Tian,et al.  Virus-mimetic nanovesicles as a versatile antigen-delivery system , 2015, Proceedings of the National Academy of Sciences.

[30]  Ronnie H. Fang,et al.  Nanoparticle biointerfacing via platelet membrane cloaking , 2015, Nature.

[31]  D. Pardoll,et al.  STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade , 2015, Science Translational Medicine.

[32]  Lynda Wyld,et al.  The evolution of cancer surgery and future perspectives , 2015, Nature Reviews Clinical Oncology.

[33]  S. B. Stephan,et al.  Biopolymer implants enhance the efficacy of adoptive T cell therapy , 2014, Nature Biotechnology.

[34]  R. Weichselbaum,et al.  STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors. , 2014, Immunity.

[35]  Jeffrey W Pollard,et al.  Tumor-associated macrophages: from mechanisms to therapy. , 2014, Immunity.

[36]  P. Robbins,et al.  Regulation of immune responses by extracellular vesicles , 2014, Nature Reviews Immunology.

[37]  Jaesung Park,et al.  Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors. , 2013, ACS nano.

[38]  M. Smyth,et al.  Making Macrophages Eat Cancer , 2013, Science.

[39]  I. Weissman,et al.  Engineered SIRPα Variants as Immunotherapeutic Adjuvants to Anticancer Antibodies , 2013, Science.

[40]  Imre Mäger,et al.  Extracellular vesicles: biology and emerging therapeutic opportunities , 2013, Nature Reviews Drug Discovery.

[41]  Sarah C. P. Williams.  Circulating tumor cells , 2013, Proceedings of the National Academy of Sciences.

[42]  Zhijian J. Chen,et al.  Cyclic GMP-AMP Is an Endogenous Second Messenger in Innate Immune Signaling by Cytosolic DNA , 2013, Science.

[43]  Zhijian J. Chen,et al.  Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway , 2013, Science.

[44]  Jens-Peter Volkmer,et al.  The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors , 2012, Proceedings of the National Academy of Sciences.

[45]  Drew M. Pardoll,et al.  The blockade of immune checkpoints in cancer immunotherapy , 2012, Nature Reviews Cancer.

[46]  Ronnie H. Fang,et al.  Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform , 2011, Proceedings of the National Academy of Sciences.

[47]  M. Wood,et al.  Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes , 2011, Nature Biotechnology.

[48]  R. Weinberg,et al.  A Perspective on Cancer Cell Metastasis , 2011, Science.

[49]  Laurie J. Gay,et al.  Contribution of platelets to tumour metastasis , 2011, Nature Reviews Cancer.

[50]  Ash A. Alizadeh,et al.  Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma , 2010, Cell.

[51]  W. Berry,et al.  A Surgical Safety Checklist to Reduce Morbidity and Mortality in a Global Population , 2009, The New England journal of medicine.

[52]  Ash A. Alizadeh,et al.  CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells , 2009, Cell.

[53]  S. Digumarthy,et al.  Isolation of rare circulating tumour cells in cancer patients by microchip technology , 2007, Nature.

[54]  Alison Stopeck,et al.  Circulating tumor cells, disease progression, and survival in metastatic breast cancer. , 2004, The New England journal of medicine.

[55]  Laurence Zitvogel,et al.  Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming , 2001, Nature Medicine.

[56]  Laurence Zitvogel,et al.  Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell derived exosomes , 1998, Nature Medicine.

[57]  J. Glenn.  Prospects and challenges. , 1967, The Journal of urology.

[58]  Ronnie H. Fang,et al.  Modulating antibacterial immunity via bacterial membrane-coated nanoparticles. , 2015, Nano letters.

[59]  S. Gordon.  Alternative activation of macrophages , 2003, Nature Reviews Immunology.

[60]  PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS Macrophage microvesicles induce macrophage differentiation and miR-223 transfer , 2022 .